Namely, MM patients displayed increased percentages of Treg, CD8+ CM cells, and CD8+ effector GZMK+, together with a reduced frequency of CD8+ GZMB+ T cells (Fig. 1C and Table S3). This evidence concerns the gene GZMK and Miyoshi myopathy.